Paclitaxel, 5-fluorouracil and hydroxyurea concurrent with radiation in locally advanced nasopharyngeal carcinoma
Annals of Oncology
Saved in:
Main Authors: | Wong, A.S.C., Soo, R.A., Lim, H.L., Goh, B.C., Lu, J.J., Shakespeare, T.P., Loh, K.S., Tan, K.S., Hsieh, W.S., Chua, E.T. |
---|---|
Other Authors: | OTOLARYNGOLOGY |
Published: |
2011
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/27362 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Paclitaxel, 5-fluorouracil and hydroxyurea concurrent with radiation in locally advanced nasopharyngeal carcinoma
by: Wong, A.S.C., et al.
Published: (2011) -
Analysis of three anticancer drugs (5-Fluorouracil, Cyclophosphamide and Hydroxyurea) in water samples by HPLC-MS/MS
by: Jareerat Usawanuwat, et al.
Published: (2015) -
Clinical pharmacokinetics of low dose paclitaxel in Asian patients with nasopharyngeal carcinoma
by: NIU HUI LIAN
Published: (2010) -
Neoadjuvant chemotherapy followed by concurrent chemoradiation for locoregionally advanced nasopharyngeal carcinoma: Interim results from 2 prospective phase 2 clinical trials
by: Kong, L., et al.
Published: (2016) -
Intensity-modulated radiation therapy without concurrent chemotherapy for stage IIB nasopharyngeal cancer
by: Tham, I.W.K., et al.
Published: (2016)